Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.
Commentary by Daniel Green MSIV …
Class act is a feature of Clinical Correlations written by NYU 3rd and 4th year medical students. Prior to publication, each commentary is thoroughly reviewed for content by a faculty member.
Commentary by Daniel Green MSIV …
Commentary by Joshua Lee MD, Ellie Grossman MD and Marc Gourevitch MD, NYU Division of General Internal Medicine
Substance abuse remains a leading cause of disease and mortality in the US, yet it is rarely …
Commentary by Josh Remick MD, NYU Senior Chief Resident
Well, it’s been quite a week! First there was Obama’s VP buzz putting the world in a frenzy, which finally culminated with his 3am …
Case presentation by Kristin Remus DO, NYU Chief Resident
Please review the posting of our prior CPC here.
When you’re ready you can download the CPC Answer.
Commentary by David Sutin MD, NYU Section 0f Geriatric Medicine
The Annual American Geriatric Society meeting, held May 2008, in Washington DC, was as usual fascinating. The meeting highlights included a lively discussion of the treatment of hypertension in the very elderly, and a talk on the emerging syndrome of …
Commentary by Antonella Surbone MD PhD FACP, Department of Medicine, New York University Medical School, Clinical Correlations Ethics Section Editor
According to the Institute of Medicine (IOM) report of April 14th, 2008, the …
Commentary by Rachana Jani MD, PGY-2
As recently reported in ShortCuts, Byetta recently made headlines after the suggestion of a mortality benefit for patients taking the drug in a small subset of the Accord study. So is this the new golden drug …
Commentary by Danise Schiliro- Chuang MD
Welcome to this week’s edition of ShortCuts. Hoping as always that this post finds you all doing well. For those of you who have taken or who are …